Lv1
38 积分 2022-09-14 加入
Remibrutinib in Chronic Spontaneous Urticaria
6小时前
待确认
Membranous nephropathy
2个月前
已完结
Trends in the drug target landscape for autoimmune diseases
2个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
2个月前
已关闭
Checkpoint kinase inhibitors: a patent review (2009 – 2010)
3个月前
已完结
The epidemiology of inflammatory bowel disease: East meets west
3个月前
已完结
TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
3个月前
已完结
Inflammatory Bowel Disease
3个月前
已完结
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
3个月前
已完结
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
4个月前
已完结
皖公网安备34019202002308
